Document Detail


Effect of cervical length on second trimester pregnancy termination.
MedLine Citation:
PMID:  21349126     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To evaluate the value of sonographic measurement of cervical length as a predictor of abortion or delivery within 24 h by misoprostol in second trimester termination of pregnancy (TOP).
MATERIAL AND METHODS: One hundred and sixty-three women underwent TOP between 14 and 26 weeks of pregnancy due to various indications. The primary outcome was abortion within 24 h. Cervical length was measured before transvaginal administration of misoprostol. The effects of cervical length, total misoprostol dose, parity, and gestational age at diagnosis on successful TOP were evaluated.
RESULTS:   One hundred and sixty-three women were eligible who met the inclusion criteria. TOP occurred in 80.5% of patients within 24 h. Parous women had shorter prolonged induction to expulsion period over 24 h (14.1% vs 28.6%, P = 0.061). Total misoprostol dose and history of abortion were parameters that affected induction to delivery period (P = 0.002 and P = 0.041). Using an optimum cutoff of 36 mm, 58.2% sensitivity and 68.2% specificity were obtained. In addition, positive and negative predictive values were 85.36% and 33.3%, respectively. Pregnant women whose preinduction cervical length was shorter than 36 mm had a shorter induction time and needed a lower total misoprostol dose to achieve TOP than women with a cervical length longer than 36 mm (P = 0.027 and P = 0.011, respectively).
CONCLUSION: Transvaginal measurement of cervical length before administration of prostaglandin analogue was not correlated with successful TOP within 24 h. It cannot be used as a predictor in light of our findings.
Authors:
Talat Umut Kutlu Dilek; Arzu Doruk; Ilay Gozukara; Huseyin Durukan; Saffet Dilek
Related Documents :
9018646 - Pregnancy outcome. influence of antiphospholipid antibody titer, prior pregnancy losses...
16953276 - Antibody profile and clinical course in primary antiphospholipid syndrome with pregnanc...
10451166 - Prevalence of antibody to trypanosoma cruzi in pregnant hispanic women in houston.
1616326 - Risk factors in the pregnancy of patients with systemic lupus erythematosus: associatio...
3128986 - Lupus pregnancy. a prospective study of placental changes.
11327206 - Nadph-diaphorase activity and nitric oxide synthase isoforms in the trophoblast of calo...
Publication Detail:
Type:  Evaluation Studies; Journal Article     Date:  2011-02-23
Journal Detail:
Title:  The journal of obstetrics and gynaecology research     Volume:  37     ISSN:  1447-0756     ISO Abbreviation:  J. Obstet. Gynaecol. Res.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-03     Completed Date:  2012-01-23     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  9612761     Medline TA:  J Obstet Gynaecol Res     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  505-10     Citation Subset:  IM    
Copyright Information:
© 2011 The Authors. Journal of Obstetrics and Gynaecology Research © 2011 Japan Society of Obstetrics and Gynecology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal
Abortion, Induced*
Adult
Cervical Length Measurement*
Female
Humans
Misoprostol
Pregnancy
Pregnancy Trimester, Second
Time Factors
Young Adult
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0E43V0BB57/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of laparoscopic stripping for ovarian cysts: Histological and clinical findings.
Next Document:  Primary myoepithelial carcinoma of the vulva and review of the literature.